Scor SE (OTCMKTS:SCRYY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the seven research firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company.
A number of research analysts have recently issued reports on the company. UBS Group downgraded Scor from a “hold” rating to a “sell” rating in a report on Tuesday, August 18th. BNP Paribas Exane downgraded Scor from an “outperform” rating to a “neutral” rating in a research report on Wednesday, June 17th.
Check Out Our Latest Report on Scor
Scor Stock Up 1.0%
Scor (OTCMKTS:SCRYY – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The financial services provider reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $4.25 billion. Scor had a net margin of 5.50% and a return on equity of 19.18%. Analysts anticipate that Scor will post 0.49 EPS for the current fiscal year.
Scor Company Profile
SCOR SE is a France-based global reinsurance company that provides risk-transfer solutions to insurance companies and other institutional clients. Its activities are primarily organized around life and health reinsurance, as well as property and casualty reinsurance.
The company offers reinsurance covering risks such as mortality, longevity, disability, medical expenses, natural catastrophes, major industrial losses and other property and casualty exposures. SCOR also provides related services, including risk modeling, actuarial expertise and investment management for insurance-related assets.
Founded in 1970, SCOR serves clients through operations in major insurance markets across Europe, North America, Asia-Pacific and other international regions.
See Also
- Five stocks we like better than Scor
- The Grocery Shelf Battle Is Changing—Who Comes Out Ahead?
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
Receive News & Ratings for Scor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scor and related companies with MarketBeat.com's FREE daily email newsletter.
